Contact
searchSearch
HMP Global
Conference Coverage
Research Shows that Health Care Costs Vary Based on HIC Status in Patients With NSCLC
06/13/2023
In an abstract presented at ASCO 2023, researchers compared real-world data on health care costs for HIC-H and HIC-C patients with NSCLC before and after they received the HIC test.
In an abstract presented at ASCO 2023, researchers compared real-world data on health care costs for HIC-H and HIC-C patients with NSCLC before and after they received the HIC test.
In an abstract presented at ASCO...
06/13/2023
Journal of Clinical Pathways
Conference Coverage
Improving Oncology Acute Care Event Prediction Through Machine Learning Algorithms
06/08/2023
Combining patient-reported outcome measures (PROMs) with electronic health record (EHR) data may improve machine learning algorithms’ ability to predict the risk of acute care events in patients with cancer.
Combining patient-reported outcome measures (PROMs) with electronic health record (EHR) data may improve machine learning algorithms’ ability to predict the risk of acute care events in patients with cancer.
Combining patient-reported...
06/08/2023
First Report Managed Care
Conference Coverage
Significant Number of Solid Tumor Drug Approvals Added Complexity to Existing Regimens
06/08/2023
A significant portion of drug approvals for nonhematologic solid cancers in the last 12 years were for indications which added to existing regimens, which could increase costs and exposure to side effects, researchers said.
A significant portion of drug approvals for nonhematologic solid cancers in the last 12 years were for indications which added to existing regimens, which could increase costs and exposure to side effects, researchers said.
A significant portion of drug...
06/08/2023
First Report Managed Care
Conference Coverage
Medicaid Expansion Linked to Early Breast Cancer Treatment, Survival Among Young Adult Women
06/02/2023
A new study showed Medicaid expansion in the United States was associated with increased receipt of timely, guideline-concordant breast cancer treatment and improved survival for young adult women.
A new study showed Medicaid expansion in the United States was associated with increased receipt of timely, guideline-concordant breast cancer treatment and improved survival for young adult women.
A new study showed Medicaid...
06/02/2023
First Report Managed Care
Conference Coverage
Breast Cancer Data Discrepancies Found Across National Tumor Registries
06/02/2023
Researchers at the 2023 ASCO Annual Meeting compared data on breast cancer cases in 3 national databases to identify differences in case coverage.
Researchers at the 2023 ASCO Annual Meeting compared data on breast cancer cases in 3 national databases to identify differences in case coverage.
Researchers at the 2023 ASCO...
06/02/2023
First Report Managed Care
Conference Coverage
FDA Oncology Approvals Commonly Involve Surrogate Endpoints, Analysis Shows
06/02/2023
In an updated analysis presented at the 2023 ASCO Annual Meeting, researchers examined the frequency with which surrogate endpoints were used to support oncology approvals from 2006 to 2022.
In an updated analysis presented at the 2023 ASCO Annual Meeting, researchers examined the frequency with which surrogate endpoints were used to support oncology approvals from 2006 to 2022.
In an updated analysis presented...
06/02/2023
First Report Managed Care
Conference Coverage
Medicare Telehealth Utilization Rates Lowest in Regions Lacking Access to Specialized Cancer Care
06/02/2023
"Advocacy and policy efforts directed towards increasing access to telehealth can ensure equitable and timely access to specialized cancer care in these regions of need," researchers said.
"Advocacy and policy efforts directed towards increasing access to telehealth can ensure equitable and timely access to specialized cancer care in these regions of need," researchers said.
"Advocacy and policy efforts...
06/02/2023
First Report Managed Care
Conference Coverage
Peripheral Myeloid Cells as Effective Prognostic Markers in Patients With NSCLC Treated With Cemiplimab
06/01/2023
Researchers evaluated the use of myeloid cells, including monocytes and eosinophilis, as prognostic biomarkers for patients with non-small cell lung cancer (NSCLC) who have been treated with cemiplimab.
Researchers evaluated the use of myeloid cells, including monocytes and eosinophilis, as prognostic biomarkers for patients with non-small cell lung cancer (NSCLC) who have been treated with cemiplimab.
Researchers evaluated the use of...
06/01/2023
First Report Managed Care
Conference Coverage
Treating Advanced Melanoma With Fianlimab and Cemiplimab
06/01/2023
Researchers at ASCO 2023 presented data on the outcomes of treating patients with advanced melanoma, including patients who previously received adjuvant therapy, with fianlimab and cemiplimab.
Researchers at ASCO 2023 presented data on the outcomes of treating patients with advanced melanoma, including patients who previously received adjuvant therapy, with fianlimab and cemiplimab.
Researchers at ASCO 2023...
06/01/2023
First Report Managed Care

Global oncology professionals gather to discuss clinical advances in every area of cancer research, the current and future landscape of oncology care, and more.

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use